Balloon Pulmonary Angioplasty Becoming Safer Over Time
MONDAY, April 10, 2023 (HealthDay News) — Balloon pulmonary angioplasty (BPA) is becoming safer over time, with a reduction seen in complications from 2013-2017 to 2018-2022, according to a review published online March 22 in JACC: Cardiovascular Int…
Learn MoreWater-Free Cyclosporine Eye Drop, 0.1 Percent, Effective for Dry Eye
MONDAY, April 10, 2023 (HealthDay News) — A water-free cyclosporine solution is effective for treating moderate-to-severe dry eye disease (DED), according to a study published online April 6 in JAMA Ophthalmology.Esen K. Akpek, M.D., from Johns Hopki…
Learn MorePartners of CRC Survivors Experience Long-Term Financial Toxicity
MONDAY, April 10, 2023 (HealthDay News) — Partners of colorectal cancer (CRC) survivors experience long-term financial toxicity that is associated with worse health-related quality of life (HRQoL), according to a study published online April 6 in JAM…
Learn MoreAnakinra Does Not Prevent Mechanical Ventilation in Severe COVID-19 Pneumonia
MONDAY, April 10, 2023 (HealthDay News) — Anakinra is not effective in reducing the need for mechanical ventilation among patients with severe COVID-19 pneumonia, according to a study published online April 7 in JAMA Network Open.Patricia Fanlo, M.D….
Learn MoreRSVpreF Safe, Effective for Preventing Respiratory Syncytial Virus Illness in Seniors
MONDAY, April 10, 2023 (HealthDay News) — The respiratory syncytial virus prefusion F protein-based (RSVpreF) vaccine appears to be safe and effective for preventing RSV-associated lower respiratory tract illness in older adults, according to a study…
Learn MoreHereditary Angioedema Remains Challenge to Diagnose, Treat
MONDAY, April 10, 2023 (HealthDay News) — Diagnosing and treating patients with hereditary angioedema (HAE) is an ongoing challenge, particularly for rural residents, according to a study published online March 12 in the Annals of Allergy, Asthma & I…
Learn MoreUrsodeoxycholic Acid Cuts SARS-CoV-2 Infection, Severity
MONDAY, April 10, 2023 (HealthDay News) — Ursodeoxycholic acid (UDCA) is associated with a reduction in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19 severity in patients with cirrhosis, according to a study publ…
Learn More